Sandy Spring Bank’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-145
Closed -$20.6K 1201
2024
Q2
$20.6K Hold
145
﹤0.01% 753
2024
Q1
$16.2K Hold
145
﹤0.01% 775
2023
Q4
$18.8K Hold
145
﹤0.01% 714
2023
Q3
$23.6K Hold
145
﹤0.01% 679
2023
Q2
$26.6K Hold
145
﹤0.01% 665
2023
Q1
$19.3K Hold
145
﹤0.01% 702
2022
Q4
$11.5K Hold
145
﹤0.01% 795
2022
Q3
$9K Sell
145
-150
-51% -$9.69K ﹤0.01% 819
2022
Q2
$16K Hold
295
﹤0.01% 733
2022
Q1
$22K Hold
295
﹤0.01% 690
2021
Q4
$22K Buy
+295
New +$17.5K ﹤0.01% 740

Other funds holding ACLS

Sandy Spring Bank's ACLS Position: Q3 2024 in Review

Sandy Spring Bank sold out of Axcelis (ACLS) in Q3 2024, closing a stake of 145 shares — an estimated $20.6K sold.

Sandy Spring Bank first reported a position in ACLS in Q4 2021 and held it in 11 quarters. The position peaked at $26.6K in Q2 2023. 368 funds tracked by Wall St. Rank hold ACLS as of Q3 2024.

  • Sandy Spring Bank reported no remaining Axcelis position as of Q3 2024 after selling out during the quarter.
  • Sandy Spring Bank sold 145 Axcelis shares in Q3 2024, an estimated $20.6K.
  • Sandy Spring Bank first reported a position in Axcelis in Q4 2021 and held it in 11 quarters.
  • Sandy Spring Bank's Axcelis position peaked at $26.6K in Q2 2023.
  • 368 funds tracked by Wall St. Rank held Axcelis as of Q3 2024.

Based on Sandy Spring Bank's 13F filing for Q3 2024, filed 25 Oct 2024.